Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson’s Disease? The Potential Role of Zolpidem in the Treatment of Parkinson’s Disease
At present, patients with advanced Parkinson’s disease (PD) are unsatisfactorily controlled by currently used anti-Parkinsonian dopaminergic drugs. Various studies suggest that therapeutic strategies based on nondopaminergic drugs might be helpful in PD. Zolpidem, an imidazopyridine widely used as s...
Saved in:
Main Authors: | Antonio Daniele, Francesco Panza, Antonio Greco, Giancarlo Logroscino, Davide Seripa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2016/2531812 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson’s Disease
by: Letizia Polito, et al.
Published: (2016-01-01) -
Progression of Nonmotor Symptoms in Parkinson’s Disease by Sex and Motor Laterality
by: Zimple Kurlawala, et al.
Published: (2021-01-01) -
Relation of Subjective Quality of Life to Motor Symptom Profile in Parkinson's Disease
by: Erica R. Appleman, et al.
Published: (2011-01-01) -
Multimodal magnetic resonance imaging studies on non-motor symptoms of Parkinson's disease
by: Weimin Qi, et al.
Published: (2025-06-01) -
Cannabis oil in treating Parkinson’s disease: improvement of motor and non-motor symptoms: a case report
by: C. T. M. I. Issa, et al.
Published: (2025-01-01)